Microinflammation in patients with Crohn's disease in clinical remission

Journal of Crohn's and Colitis

Volumn 2, Issue 4, 2008, Pages 310-314

  Maharshak, Nitsan ^a,b   Zilberman, Liaz ^a,b   Arbel, Yaron ^a,b   Shapira, Itzhak ^a,b   Berliner, Shlomo ^a,b   Arber, Nadir ^a,b   Dotan, Iris ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Crohn's disease; Inflammatory markers; Remission

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

EID: 56449086989     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.05.001     Document Type: Article

References (19)

1. Vermeire S., Van A.G., and Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 55 (2006) 426-431
2. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 11 (1999) 448-454
3. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
4. Best W.R., Becktel J.M., Singleton J.W., and Kern F.J. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 70 (1976) 439-444
5. Conroy C.A., and Cattell R. Infliximab treatment for Crohn's disease. Postgrad Med J 77 (2001) 436-440
6. Chamouard P., Richert Z., Meyer N., Rahmi G., and Baumann R. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease. Clin Gastroenterol Hepatol 4 (2006) 882-887
7. Macfarlane P.I., Miller V., Wells F., and Richards B. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 5 (1986) 93-96
8. Kushner I., Rzewnicki D., and Samols D. What does minor elevation of C-reactive protein signify?. Am J Med 119 (2006) 166.e17-166.e28
9. Berliner S., Rogowski O., Aharonov S., Mardi T., Tolshinsky T., Rozenblat M., et al. Erythrocyte adhesiveness/aggregation. A novel biomarker for the detection of low grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J 149 (2005) 260-267
10. Rogowski O., Toker S., Shapira I., Melamed S., Shirom A., Zeltser D., et al. Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol 95 (2005) 152-155
11. Zeltser D., Rogowski O., Mardi T., Justo D., Tolshinsky T., Goldin Y., et al. Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein. Atherosclerosis 176 (2004) 297-301
12. International committee for standardization in hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2 (1965) 235-254
13. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel 17 (1957) 237-246
14. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45 (1999) 2136-2141
15. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
16. Sattar N., McCarey D.W., Capell H., and McInnes I.B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108 (2003) 2957-2963
17. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
18. Biasucci L.M. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110 (2004) e560-e567
19. Berliner S., Shapira I., Toker S., Melamed S., Shirom A., and Rogowski O. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol Dis 34 (2005) 135-140